At the news
? NEUTRALIMPACT 4/10 EFFECT filed Nov 13, 2026 at 00:15 ET
Werewolf Therapeutics' S-4 registration statement (File No. 333-299079) became effective on November 12, 2026, under the 1933 Act. This effectiveness allows the company to proceed with the business combination or exchange offer contemplated by the S-4, likely involving the issuance of securities in connection with a merger or acquisition.
- Effectiveness date: November 12, 2026
- Registration statement type: S-4 (business combination or exchange offer)
- SEC File Number: 333-299079
- Company: Werewolf Therapeutics, Inc. (Ticker: HOWL)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access